Whitehawk Therapeutics (WHWK) Asset Utilization Ratio (2020 - 2025)

Whitehawk Therapeutics (WHWK) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio fell 86.5% year-over-year to 0.04 in Q4 2025; TTM through Dec 2025 was 0.04, a 86.5% decrease from a year earlier, with the FY2025 full-year figure at 0.06, down 74.79% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.04, down from 0.08 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for WHWK reached as high as 0.98 in Q1 2021 and fell as low as 0.04 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.2 across 5 years, with a median of 0.15 in 2022.
• Across the five-year window, Asset Utilization Ratio plunged 89.85% in 2021 and soared 122.56% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.09 in 2021, then declined by 6.95% to 0.08 in 2022, then surged by 122.56% to 0.18 in 2023, then jumped by 86.06% to 0.33 in 2024, then plunged by 86.5% to 0.04 in 2025.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.04 in Q4 2025, 0.08 in Q3 2025, and 0.1 in Q2 2025.